Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Glucantime in Children vs Adults With Cutaneous Leishmaniasis
IRCT138804162082N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Sep 2006; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT138804162082N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138804162082N1.